Though I agree with Gooshen, the share price will likely drop back to below RM3 in the next few months after BI adjustment which may be announce quite soon.

The HK listing is really putting pressure on share price.

Additional 1.5 bil shares is really not beneficial to anyone including itself.

It's already flush with sufficient cash for expansion.

Should just buyback shares and cancel it to improve EPS.

The SG listing also didn't really help much to promote the company and worst still the ESG issues really put Msia image like a sweat shop.

Gooshen, share with you another secret.

Inari client's Broadcom is having solid demand.

With current batu kawan factory with 200,00 sf utilisation roducing RM90mil per quarter, the full utilisation of 680,000sf will produce at least RM270mil per quarter, that's more than RM1 billion in PAT per annum.

https://www.bloomberg.com/news/articles/2021-03-04/broadcom-ceo-says-sales-are-real-as-chip-orders-flood-in

It's expensive if you compare with other EMS players eg:ATA IMS, SKPresources, VS, PIE,etc

Most of them having 50% discount to their forward PE.

If UWC deserves such huge premium , is either they have internal R&D to develop their own products, high tech barrier which other EMS player are 4-5 years behind or UWC is the only player in ASEAN that is able to produce it.

Maybe you can answer this.

@robert88888

EPF was part of the early investor below 5% during IPO.

Only recent purchase cause it to breached the 5% where they need to disclose.

EPF had always has many funds, some purchase and some sell depends on their portfolio and rebalancing policy.

To be honest, I felt that Wong had lost his edge. BOD should oust him for uttering such ideas.

He's now diversifying into healthcare related biz just becoz gloves, vaccine and test kits was doing well recently.

His current biz eg: gov service provider and digitizing them is lucrative and should expand this similar concept to other countries eg: Cambodia, Vietnam,Indonesia,etc

Yup.
At RM2, there's enough liquidity already.

Maybe counter like F&N, Nestle, Panasonic, MPI, Dlady need BI.

Not sure why Wong is thinking that currently his counter lacks liquidity.
Something fishy?

@scholez18

It's because their share base is high at 3.6 billion.

1% of that is already 36 million shares/RM72 million in value.

It's difficult to push unless there's catalyst eg:rumours/news that excite the market to buy more.

I think the current price is still too expensive for an EMS player.
Trading close to forward pe=35 will be more attractive.

Amirul should just buy from the open market.
Still cheaper than he bought from Mustakim.

Too much supply of Glove

China glove makers Blue Sail Medical and Intco Medical aim to raise their nitrile glove production capacities. Blue Sail Medical intends to increase its production to 36.1 billion pieces per annum by end-2023 from 4.3 billion pieces as of end-2019.

On the other hand, Intco plans to expand its nitrile glove capacity to 59.2 billion pieces per annum by end-2023, from 5 billion pieces at end-2019.

The same technique again.
Was wondering if he's buy or sell call is involving actual money?
Or Uncle is just writing blogs.

Gooshen is here also.
Brief you also.

Key takeaway:

-Long term biz and high barrier to entry(less than 20 companies in the world.
-5G, IOT, EV beneficiary
-The Group is looking to expand its capacity in Taiwan by setting up a new state of the art facility which is targeted for completion in year 2022.
-Group is also planning to set up a new facility in US to further support its TSMC expansion in Arizona.
-Frontken has proposed the bonus issue of shares and free warrants on the basis of 1 bonus shares and 1 free warrant for every 2 existing shares.
-the Group has declared its second single tier dividend of 2.8 sen per share which make up of total dividend of 4 sen for the FY20 as compared to 2.5 sen in FY19.

Currently Taiwan is experiencing worst drought in 50 years.

Hopefully, frontken's client TSMC is able to find ways to reduce the impact which will last up to May 2021.

Expecting some weakness in earnings impacting the month of April to May period.

Gooshen,

Good opportunity for you buy now. Later no more at level 3.

Gooshen,

Share with you a secret.
Inari Batu Kawan plant existing plant for the 200,000 sf space is 90% utilised for production. The Q2 yielded RM90mil PAT with this current capacity and utilisation.

The current factory still have unused space of 480,000 sf.

Assumption that price of product manufactured remains constant, you are looking at RM270mil PAT per quarter at full utilisation of the 680,000 sf batu kawan factory.

That's more than RM1bil PAT per annum.

Based on IBs report, the company is securing a few new customer to fulfil the space.

1. chip & assembly
2. EV power management module
3. Swiss client-sub module assembly
4. HK client-proprietary optical transceiver


https://klse.i3investor.com/blogs/kenangaresearch/2021-01-27-story-h1540183783-Inari_Amertron_Leader_Has_Spoken.jsp

News article mentioned LSS4 will likely be out his week.

Hopefully can secure a sizeable portion for owned asset and also JV with other smaller solar player who had secured part of the LSS4.

Target 50MW to 100MW with project size between RM500mil to RM1bil

Client Broadcom reported good revenue &earnings for quarter ending Jan2021.

Inari yet to report Jan-Mar2021.

Expecting good result.

https://investors.broadcom.com/news-releases/news-release-details/broadcom-inc-announces-first-quarter-fiscal-year-2021-financial

Hope to see the company secure LSS4 with ownership/concessionaire.
It'll help to provide recurring income like IPP

Almost bottom, good to buy on weaknesses.

After looking deeper into this company and understanding it's biz structure, only notice that UWC is an EMS player.

Similar with other EMS player like ATA IMS, VS, SKPres,PIE, Uchitec,etc

Most of them are trading between PE 20-40

UWC does not innovate their own products but build based on clients design. Eg: Replicate and mass produce

Then it would NOT command a higher PE or PE premium. Probably the average of 30x forward.

The last sermon part 2

Gooshen, 5G technology solution does not end in 1 week or 1 month or 1 year.

If we looks at Inari's previous earnings and share price movement during the implementation of 4G wordwide, Inari started to benefit from it, 2-3 years (2012-2013) after first introduction in developed nation eg: US,UK,Japan.

It continues to have massive earnings from 2012 to 2016 of almost 900% with share price appreciating more than 1000% in that period.

Make your own decision for 5G

Below RM3 will be a better buy.
No need to rush.
Blended ASP will be adjusting lower from 3rd quarter 2021 onwards to 2nd quarter 2022 from USD85/1000 to USD45/1000
Backlog orders for 2022 will reduce and normalise to between 3-4 mths from current 12mths.

It's good time to buy in.
Almost bottom.

Hopefully, Supermax doesn't limit down.

Really can't imagine what it could do to uncle koon.

Already margin call for him. If he doesn't rectify it, his shares would be force sale. Looks like it's today.

Good profit expected for the rainy season

Company not so generous on the dividend.

Next 2Q will be dry season earnings but still expecting at least RM55mil per quarter.

To be honest
Both are equally important

However, in order to select a good company to invest FA comes first, follows by TA to get good entry and exit price.

I think KYY is very confused.

Vitrox and Uchitec is not in the same category.
Uchitec is EMS player
Vitrox is ATE player.

Their biz are unique and serve different customers.

Get your facts right.

I suggest all of you here to go and study OSAT and semicon players.

Then you can understand the entire value chain.

Topglove share buyback from RM8 to RM5 ++


Looks like it may need to declare some impairment to the buybacks values to reflect current value.

This coming QR result will include impairment for the share investment portion.

Stock: [INARI]: INARI AMERTRON BHD

Feb 10, 2021 11:42 AM | Report Abuse

Inari is going to announce Q2 result in 2 weeks time.

Expect PAT to hit close to Rm100mil 1st time in history.

Share price should reflect naturally and dividend at least 2.5cent.

Gooshen is only looking at daily share price, we are looking are company profits, dividends and BI.

----------------------------------------------------------------------------------------

Almost close to my prediction

Wow
Quite good results.

Almost hit my own expectation of RM100mil PAT.

Good idea Sogbashen .

Will buy some TSMC instead since TSMC is pure semicon play.

Whereas, Frontken has it's o&g link, where it may tilt the other way when crude oil price plunge.

Agree with arv18

Stock can continue to fall for no reason.

Stock market is always irrational.

Though there is a floor with good support.

My opinion for you Uncle KYY since you're holding Topglove (RM3-RM3.50) and Supermax (RM2.70-RM3.00)

Hope you top up for long term.

With latest result, TSMC seems more attractive than Frontken in terms of PE

QR result looks good.
Though I was expecting better profit margin.

Smaller players under similar biz eg: Dufu Technology, PIE Industrial,etc

It's classify under industrial products and services sector as it is similar biz with competitors like VS Industry, SKP Resources, ATA IMS, etc

No news on US CBP
Almost 8 months already.
Likely to have loss some market share(in US) to others.

I suggest you either cut loss(27%) portfolio or top up more and keep for long term >5 years or switch to other recovery stocks.

Writing blogs won't push up the stocks price.

You have to acknowledge that you came to the party late.

There's Astrazeneca, Sinovac, J&J, Moderna, Sputnik doesn't require deep freeze/ultra-cold unit.

Only Pzifer requires it.

I believe in any single country, source of vaccine will be coming from multiple sources.

I think minimal contribution to Uchi.

Revenue didn't grow this quarter as compared to previous quarter. A little disappointing.
Hopefully is not an indication of revenue had peaked.

Glove is definitely required for vaccination.
7.6 bil ppl needs 7.6 bil pairs.

Supermax will produce additional 10 billion gloves by end 2021.
Topglove will produce additional 18 billion gloves by end 2021.
Harta will produce additional 4 billion gloves by end 2021.
Kossan additional 2 billion gloves by end 2021.

This is only the additional supply from top4 largest manufacturer.
Haven't include 5th to 10th largest supply capacity.
Haven't include new glove wannabes.

I think it will be another failed takeover

Tech is the future.
If you notice, Forbes top 10 richest man in the world, 7 of them doing tech biz, 1 of them invest in tech and 2 not tech.

Times had change

But none of them doing gloves

currently oil and gas rotating equipment services contributes 17% to the total revenue.
Higher oil prices will encourage more upstream activity that benefits Frontken, though o&g biz is not a big portion as compared with semicon biz.

The bonus issue will be credit on 17/2/2021 night.
So on 18/2/2021 morning before trading begins ,will be available in your account.

I think JFTECH probably need 1-2 yrs before it reach the min RM20 million PAT to qualify for main board listing.

Lol.

Buy and invest in the company's good 5G prospect.

This applies to other companies as well.

Unless you are full time day trader, else investing in a company is a passive role where the CEO is working hard for me and my money.